Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort study.
- DOI
- 10.1186/s13690-026-01895-2
- Published
- 2026 Mar 25
- Container
- Archives of public health = Archives belges de sante publique
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13690-026-01895-2,
title = {Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort study.},
author = {Lix LM and Dahl M and St-Jean A and Golandouz HM and Ling V and Janzen D and Ronksley PE and Scory TD and Dutton DJ and Manning D and Carney G and Perras C and Ernst P and Canadian Network for Observational Drug Effect Studies (CNODES) Investigators},
year = {2026},
journal = {Archives of public health = Archives belges de sante publique},
doi = {10.1186/s13690-026-01895-2},
url = {https://doi.org/10.1186/s13690-026-01895-2}
}RIS
TY - JOUR TI - Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort study. AU - Lix LM AU - Dahl M AU - St-Jean A AU - Golandouz HM AU - Ling V AU - Janzen D AU - Ronksley PE AU - Scory TD AU - Dutton DJ AU - Manning D AU - Carney G AU - Perras C AU - Ernst P AU - Canadian Network for Observational Drug Effect Studies (CNODES) Investigators PY - 2026 JO - Archives of public health = Archives belges de sante publique DO - 10.1186/s13690-026-01895-2 UR - https://doi.org/10.1186/s13690-026-01895-2 ER -
APA
LM, L., M, D., A, S., HM, G., V, L., D, J., PE, R., TD, S., DJ, D., D, M., G, C., C, P., P, E., & Investigators, C. N. F. O. D. E. S. (. (2026). Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort study.. Archives of public health = Archives belges de sante publique. https://doi.org/10.1186/s13690-026-01895-2
Source records
- pubmed · retrieved 2026-09-25T19:13:52.804Z